Newsletter - Banner

Breadcrumb

Navigation Menu

Asset Publisher

Early treatment trial of hydroxychloroquine shows no symptomatic benefit for COVID-19 patients

Adult outpatients with mild symptoms of COVID-19 don’t benefit from taking hydroxychloroquine

A good showing for the IDIGH Program in 2020-2021 FRQS awards

Congratulations to researchers and trainees!

Recipient of the 2020-2021 Dr. Margaret Becklake Fellowship: Mikashmi Kohli

A postdoctoral fellow from the RI-MUHC is recognized for international work on TB diagnostics

Three COVID-19 projects at the RI-MUHC to receive CIHR funding

A $109M fund aims to mitigate impact of the pandemic on care delivery in Canada and beyond, as well as contribute to better understanding of the disease

COVID-19 pandemic: Looking back to better tackle future challenges

In two recent studies, RI-MUHC researchers provide useful information for evaluating public health strategies

Innovation Moves Online for the 2020 McGill Clinical Innovation Competition

RI-MUHC research team, Emily McDonald and Todd C. Lee, ties for Marika Zelenka Roy Innovation Prize

COVID-19 impact on cancer patients: MUHC researchers take part in a multinational study

Published in The Lancet, the study reveals cancer-specific factors associated with increased mortality

Hydroxychloroquine not effective in preventing the development of COVID-19 when used as post-exposure prophylaxis

A new study suggests that hydroxychloroquine is not effective in preventing the development of COVID-19 in individuals exposed to SARS-CoV-2

Results of MI4 Emergency COVID-19 Research Funding (Round 2)

RI-MUHC researchers awarded MUHC Foundation funding for a second round of projects with potential impact in a short timeframe

Looking to produce a COVID-19 vaccine in the greenhouse

RI-MUHC researcher working with Quebec-based company on a plant-based technique

We Care About Rare!

Researchers, advocates and patients gather on Rare Disease Research Day at the RI-MUHC

RI-MUHC researchers review diagnostic tests for COVID-19

Study published in the Annals of Internal Medicine

Results of MI4 Emergency COVID-19 Research Funding (Round 1)

RI-MUHC researchers awarded MUHC Foundation funding for projects with potential impact in a short timeframe

FRQ to create a province-wide COVID-19 Biobank

RI-MUHC researchers take leading roles in the initiative

$4 M for MUHC Foundation COVID-19 Emergency Fund

Prominent Montreal families come together to fight the pandemic

Reducing confusion about the coronavirus (COVID-19)

RI-MUHC researchers provide expertise and advice

RI-MUHC innovative clinical trial assesses hydroxychloroquine for prevention and treatment of COVID-19

Initially restricted to health care workers in Quebec, the clinical study is now open to all eligible adults

COVID-19 coronavirus and tuberculosis: We need a damage control plan

Dr. Madhukar Pai explains why TB services might be one of the biggest casualties of the pandemic

RI-MUHC researcher on Innovation Panel at the U.S. National Academy of Sciences

Dr. Nitika Pant Pai speaks out on global microbial threats

Vitamin E effective, safe for fatty liver in HIV patients

RI-MUHC researcher Dr. Giada Sebastiani is lead author of study published in the journal AIDS

Overcoming the greatest obstacle to curing HIV

RI-MUHC researcher participated in the groundbreaking study published in Nature

The Pfizer Investigator Training Program comes to the RI-MUHC!

Clinical research educational training program benefits researchers, staff and students at the inaugural event

Reaching beyond the hallowed halls of academe

“With science under attack, scientists have little choice but to step into the limelight and fight for what matters most” – Dr. Madhukar Pai

Meeting the global health challenge of worms that cause disease

Theresa Gyorkos has dedicated her career to understanding and reducing the harms caused by parasitic worm infection
— 25 Items per Page
Showing 1 - 25 of 113 results.